FDA clears Salix anti-diarrheal for HIV patients - MarketWatch

[INCIID News Feed]

Economic Times
<img alt="" height="1" width="1" />
FDA clears Salix anti-diarrheal for HIV patients
MarketWatch
The Food and Drug Administration has approved the first anti-diarrheal drug for HIV/AIDS patients, Salix Pharmaceuticals Ltd.&#39;s (NASDAQ:SLXP) Fulyzaq. The drug, also known as crofelemer, is meant to relieve symptoms of noninfectious diarrhea in patients ...
Salix Wins FDA Approval of Dragon&#39;s Blood Drug for DiarrheaBloomberg
Glenmark&#39;s US Partner Gets FDA Nod To Market Crofelemer TabletsRTT News
Glenmark&#39;s US partner gets USFDA nod for anti-diarrhoea drugIndia.Com Health
FiercePharma -FierceBiotech -Financial Express
all 69 news articles &raquo;


More...